ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 228120 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 228120; 2) Community: the network communities that were significantly associated with the response to NSC 228120; 3) Molecule: the relationships between components within communities and NSC 228120; 4) MDR: the compounds that were significantly associated with the NSC 228120.

NSC Compound Enrichment Correlation
NSC 719923 Null 0.0375780807984392 -0.01535785
NSC 720177 Null 0.0375780807984392 0.49930278
NSC 720426 Null 0.0375780807984392 -0.31024883
NSC 744989 7-methoxy-8-[(5-2-methoxy-4-[(E)-3-(2,4-dimethyl-3-quinolyl)-3-oxo-1-propenyl]phenoxybutyl)oxy]-2,3,5,11a-tetrahydro-1H-benzo[e]pyrrolo[1,2-a][1,4]diazepin-5-one 0.0375780807984392 0.30554519
NSC 758359 N3-[1-(3-phenoxybenzyl)-1H-1,2,3-triazol-4-yl]methyl-2-(4-fluoroanilino)nicotinamide 0.0375780807984392 -0.2228691
NSC 19441 FDA 0283 0.0399098711718627 0.20419062
NSC 668499 Null 0.039909871171863 -0.09945615
NSC 677274 Uracil, 3-methyl-6-(phenylhydrazino)- 0.039909871171863 0.43551917
NSC 684910 2,6-Pyrimidinediamine, 4-chloro-5-[(4-chlorophenyl)azo]- N(6)-[[1-(hydroxymethyl)-3-(phenylmethoxy)cyclobutyl] methyl]-, (Isomer B)-, stereoisomer of NSC-684909 0.039909871171863 0.29285476
NSC 686425 Null 0.039909871171863 -0.0125498
Total:50  Current:37    [First] [Prev] [Next] [Last]